Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed240%
terminated120%
active_not_recruiting120%
recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
completednot_applicable

Cardiovascular Responses in Burn Survivors During Exercise

NCT06709781
terminatednot_applicable

Heat Waves and the Elderly With COPD

NCT06295523
recruitingnot_applicable

Heat Waves and the Elderly - Cooling Modalities

NCT05484739
active_not_recruitingnot_applicable

Skin Surface and Intradermal Temperature Responses to Heat Stress

NCT06593067
completednot_applicable

Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial

NCT01860248

Clinical Trials (5)

Showing 5 of 5 trials
NCT06709781Not Applicable

Cardiovascular Responses in Burn Survivors During Exercise

Completed
NCT06295523Not Applicable

Heat Waves and the Elderly With COPD

Terminated
NCT05484739Not Applicable

Heat Waves and the Elderly - Cooling Modalities

Recruiting
NCT06593067Not Applicable

Skin Surface and Intradermal Temperature Responses to Heat Stress

Active Not Recruiting
NCT01860248Not Applicable

Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5